High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study

doi:10.3748/wjg.v29.i23.3645

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3626)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

1995

Figures (1-6)

426

Tables (1-2)

389

Sum=2915

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

165

Download

412

Sum=577

Jun 21, 2023 (publication date) through Jan 25, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jun 21, 2023; 29(23): 3645-3657
Published online Jun 21, 2023. doi: 10.3748/wjg.v29.i23.3645

Full Size Figure Download Figure

Figure 1 Expression of NPAS2 in gastric cancer. The expression of NPAS2 in tumor tissues of gastric cancer was detected by immunohistochemical staining and compared with adjacent normal tissues. High expression of NPAS2 in gastric cancer and low expression in adjacent non-cancerous tissue.

Citation: Cao XM, Kang WD, Xia TH, Yuan SB, Guo CA, Wang WJ, Liu HB. High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study. World J Gastroenterol 2023; 29(23): 3645-3657
URL: https://www.wjgnet.com/1007-9327/full/v29/i23/3645.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i23.3645